Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$23,085,705
+$3,284,981 QoQ
Shares Held
91,741
+0.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
3.22%
of 13F equity value
Holder Rank
#565
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 6%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gryphon Financial Partners LLC holds $43,846,091 across 10 Drug Manufacturers - General names. ABBV ranks #1 (52.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
91,741 | $23,085,705 | |
| 2 | LLY |
ELI LILLY & Co
|
6,418 | $7,697,942 | |
| 3 | JNJ |
Johnson & Johnson
|
25,825 | $6,558,775 | |
| 4 | AMGN |
Amgen Inc
|
5,868 | $2,124,920 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,044 | $2,061,654 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,540 | $826,263 | |
| 7 | GSK |
GSK plc
|
15,580 | $816,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,157 | $239,526 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,085,705 | 91,741 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $19,800,724 | 91,042 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $20,331,040 | 88,980 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $20,360,469 | 87,935 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,959,726 | 91,368 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $18,117,193 | 86,470 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $15,296,237 | 86,079 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $16,820,555 | 85,176 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $14,742,486 | 85,952 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $15,380,529 | 84,462 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $13,056,066 | 84,249 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,329,944 | 82,718 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $11,192,290 | 83,072 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,246,515 | 83,118 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $13,436,577 | 83,142 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $11,146,273 | 83,051 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,554,831 | 81,972 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $13,425,786 | 82,819 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $11,361,955 | 83,914 | Shares | Other | 2022-02-01 | |
| 2021-09-30 | $9,079,956 | 84,175 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $9,309,581 | 82,649 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $9,148,917 | 84,540 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $8,760,261 | 81,757 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $7,033,563 | 80,301 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $7,830,149 | 79,753 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $6,083,389 | 79,845 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||